SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-004165
Filing Date
2018-03-29
Accepted
2018-03-29 17:00:36
Documents
4
Period of Report
2018-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 39750
2 ex10-1.htm EX-10.1 304507
3 ex99-1.htm EX-99.1 12669
4 image_001.jpg GRAPHIC 7296
  Complete submission text file 0001493152-18-004165.txt   368332
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 18723699
SIC: 2835 In Vitro & In Vivo Diagnostic Substances